Half Yearly Results Results Snapshot
Figures in Rs cr
Standalone Half Yearly Results
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2024 is 29.23% vs 22.01% in Sep 2023
Standalone Net Profit
Growth in half year ended Sep 2024 is 32.49% vs 54.63% in Sep 2023
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2024 is 42.01% vs 61.29% in Sep 2023
Interest
Growth in half year ended Sep 2024 is 67.33% vs 46.15% in Sep 2023
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2024 has improved from Sep 2023
Compare Half Yearly Results Of Fredun Pharma With
Figures in Rs cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
184.43
4,933.00
-4,748.57
-96.26%
Other Operating Income
1.74
0.00
1.74
Total Operating income
186.17
4,933.00
-4,746.83
-96.23%
Raw Material Cost
125.79
386.36
-260.57
-67.44%
Purchase of Finished goods
0.00
988.27
-988.27
-100.00%
(Increase) / Decrease In Stocks
7.54
15.23
-7.69
-50.49%
Employee Cost
6.68
1,047.96
-1,041.28
-99.36%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
8.25
0.00
8.25
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
13.47
1,170.95
-1,157.48
-98.85%
Total Expenditure (Excl Depreciation)
161.73
3,608.77
-3,447.04
-95.52%
Operating Profit (PBDIT) excl Other Income
24.44
1,324.23
-1,299.79
-98.15%
Other Income
0.00
200.59
-200.59
-100.00%
Operating Profit (PBDIT)
24.44
1,524.82
-1,500.38
-98.40%
Interest
9.22
8.18
1.04
12.71%
Exceptional Items
0.00
61.23
-61.23
-100.00%
Gross Profit (PBDT)
15.22
1,516.64
-1,501.42
-99.00%
Depreciation
2.11
168.82
-166.71
-98.75%
Profit Before Tax
13.10
1,347.82
-1,334.72
-99.03%
Tax
4.69
261.13
-256.44
-98.20%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
8.40
1,086.69
-1,078.29
-99.23%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
8.40
1,147.92
-1,139.52
-99.27%
Equity Capital
4.72
40.06
-35.34
-88.22%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.80
28.66
-10.86
-37.89%
Diluted Earnings per share
17.80
28.61
-10.81
-37.78%
Operating Profit Margin (Excl OI)
13.25%
26.84%
0.00
-13.59%
Gross Profit Margin
8.25%
30.74%
0.00
-22.49%
PAT Margin
4.55%
22.03%
0.00
-17.48%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 184.43 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 29.23% vs 22.01% in Sep 2023
Half Yearly - Standalone Net Profit
Standalone Net Profit 8.40 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 32.49% vs 54.63% in Sep 2023
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 24.44 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 42.01% vs 61.29% in Sep 2023
Half Yearly - Interest
Interest 9.22 Cr
in Sep 2024Figures in Rs Cr
Growth in half year ended Sep 2024 is 67.33% vs 46.15% in Sep 2023
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.25%
in Sep 2024Figures in Rs %
Growth in half year ended Sep 2024 has improved from Sep 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
